Viewing Study NCT06463834


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-01-09 @ 4:47 AM
Study NCT ID: NCT06463834
Status: RECRUITING
Last Update Posted: 2024-06-18
First Post: 2024-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Sponsor: Fujian Cancer Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-20
Start Date Type: ACTUAL
Primary Completion Date: 2025-03-19
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-03-19
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-13
First Submit QC Date: None
Study First Post Date: 2024-06-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-17
Last Update Post Date: 2024-06-18
Last Update Post Date Type: ACTUAL